Novel Neural Network Biomarker of Botulinum Toxin Efficacy in Isolated Dystonia.

Dongren YaoLena C O'FlynnKristina Simonyan

Published in: Annals of neurology (2022)

DystoniaBoTXNet and its treatment biomarker have a high translational potential as an objective, accurate, generalizable, fast, and cost-effective algorithmic platform for enhancing clinical decision-making for BoTX treatment in patients with isolated dystonia. This article is protected by copyright. All rights reserved.

Keyphrases

neural network
botulinum toxin
decision making
early onset
deep brain stimulation
risk assessment
single cell
smoking cessation
human health